Evidence map›Paper›PMID 27521377›Full record

Trial reportJournal of neurology, neurosurgery, and psychiatry2016

Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial.

Georgina Charlesworth, Karen Burnell, Nadia Crellin, Zoe Hoare, Juanita Hoe, Martin Knapp, Ian Russell, Jennifer Wenborn, Bob Woods, Martin Orrell

2 registry-linked trialsOpen access · bronzeAbstract readComparative StudyMulticenter StudyPragmatic Clinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of neurology, neurosurgery, and psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04047238 nacompletednot on this mapstarted 2019, after this paper: background citation

Multicentre Randomized Controlled Study About the Effect of Individual Reminiscence Therapy on Cognition in Elderly People With Neurocognitive Disorder Attending Social Responses

TypeinterventionalSponsorRsocialform - Geriatria, LdaRan2019 to 2019Enrolled251ConditionsCognitive Impairment, Cognitive Decline, Dementia, Neurocognitive DisordersArmsReminiscence Therapy
NCT04658394 nacompletednot on this mapstarted 2021, after this paper: background citation

Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders: A Multicentre Randomised Controlled Trial in Azores Archipelago

TypeinterventionalSponsorRsocialform - Geriatria, LdaRan2021 to 2021Enrolled122ConditionsDementia, Neurocognitive Disorders, Cognitive Impairment, Cognitive DysfunctionArmsReminiscence therapy
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Reminiscence therapy for dementia.The Cochrane database of systematic reviews · 2018
    Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Pragmatic clinical trial design in emergency medicine: Study considerations and design types.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Georgina CharlesworthUCL Research Department of Clinical, Educational and Health Psychology, London, UK.ORCID http://orcid.org/0000-0002-5278-1756
Karen BurnellSchool of Health Sciences and Social Work, University of Portsmouth, Portsmouth, UK.
Nadia CrellinNorth East London NHS Foundation Trust, Ilford, UK.
Zoe HoareNWORTH Clinical Trials Unit, Bangor University, Bangor, UK.
Juanita HoeDivision of Psychiatry, University College London, London, UK.
Martin KnappLondon School of Economics, London, UK.
Ian RussellSwansea University Medical School, Swansea, UK.
Jennifer WenbornDivision of Psychiatry, University College London, London, UK.
Bob WoodsDSDC Wales, Bangor University, Bangor, UK.
Martin OrrellInstitute of Mental Health, University of Nottingham, Nottingham, UK.
Bangor University · GBUniversity College London · GBDepartment of Health and Social Care · GBLondon School of Economics and Political Science · GBNorth East London NHS Foundation Trust · GBSwansea University · GBUniversity of Nottingham · GBUniversity of Portsmouth · GB

Funding

Department of Health RP-PG-0606-1083
6 · The paper itself

Abstract

objectiveThe objective of this study was to evaluate peer support and reminiscence therapy, separately and together, in comparison with usual care for people with dementia and their family carers.

designFactorial pragmatic randomised trial, analysed by treatment allocated, was used for this study.

settingThe trial ran in Community settings in England.

participantsPeople with dementia and their family carers were the participants.

interventionsTreatment as usual (TAU) plus one of the following: one-to-one peer support to family carers from experienced carers (Carer Supporter Programme; CSP), group reminiscence therapy (Remembering Yesterday, Caring Today; RYCT) for people with dementia and carers, both or neither.

main outcome measuresPrimary outcomes included health-related quality of life (SF-12) for carers and quality of life (QoL-AD) for people with dementia; secondary outcomes included quality of relationship for carers and people with dementia; both were collected by blinded assessors at baseline, 5 and 12 months (primary end point).

resultsOf 291 pairs recruited, we randomised 145 (50%) to CSP (71% uptake) and 194 (67%) to RYCT (61% uptake). CSP and RYCT, separately or together, were not effective in improving primary outcomes or most secondary outcomes. For CSP versus 'no CSP', adjusted difference in means was 0.52 points on the SF-12 (95% CI -1.28 to 2.32) and -0.08 points on the QoL-AD (95% CI -1.70 to 1.56). For RYCT versus 'no RYCT', the difference was 0.10 points on the SF-12 (95% CI -1.72 to 1.93) and 0.51 points on the QoL-AD (95% CI -1.17 to 2.08). However, carers reported better relationships with the people with dementia (difference 1.11, 95% CI 0.00 to 2.21, p=0.05). Comparison of combined intervention with TAU, and of intervention received, suggested differential impacts for carers and persons with dementia.

conclusionsThere is no evidence from the trial that either peer support or reminiscence is effective in improving the quality of life. TRIAL REGISTRATION NUMBER: ISRCTN37956201; Results.

Indexed as

Cost of IllnessMemory, EpisodicPeer GroupSocial SupportActivities of Daily LivingAgedAged, 80 and overAlzheimer DiseaseCaregiversDisability EvaluationFemaleHealth StatusHumansLondonMaleMiddle Aged

Identifiers

PMID27521377
PMCPMC5099314
OpenAlexW2512657511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.